Health Care & Life Sciences » Pharmaceuticals | Rohto Pharmaceutical Co. Ltd.

Rohto Pharmaceutical Co. Ltd. | Ownership

Companies that own Rohto Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
SPARX Asset Management Co., Ltd.
6,706,800
5.69%
0
5.63%
03/31/2018
MFS International (UK) Ltd.
6,337,100
5.37%
8,500
0.43%
07/31/2018
Nomura Asset Management Co., Ltd.
3,373,398
2.86%
-860,962
0.06%
07/31/2018
The Vanguard Group, Inc.
2,338,906
1.98%
21,800
0%
07/31/2018
International Value Advisers LLC
2,153,700
1.83%
-25,100
0.73%
03/31/2018
OppenheimerFunds, Inc.
1,515,333
1.29%
-183,000
0.03%
02/28/2018
Norges Bank Investment Management
1,251,699
1.06%
-110,661
0.01%
12/31/2017
BlackRock Fund Advisors
915,800
0.78%
0
0%
09/06/2018
Daiwa Asset Management Co. Ltd.
891,800
0.76%
10,300
0.03%
07/31/2018
Nikko Asset Management Co., Ltd.
812,199
0.69%
-96,801
0.02%
08/20/2018

About Rohto Pharmaceutical Co.

View Profile
Address
1-8-1 Tatsumi-nishi
Osaka Osaka 544
Japan
Employees -
Website http://www.rohto.co.jp
Updated 07/08/2019
Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. Its products include eye drops, contact lens care, dermal medicines, skin care, internal medicines, cold remedies, test kits, and denture cleansers. Its operations are carried out through the following segments: Japan, America, Europe, Asia, and Others.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.